Faaliyet kârı · 2025 mali yılı
| 1 | Johnson & JohnsonJNJ | $32,6B |
|---|---|---|
| 2 | Eli LillyLLY | $25,7B |
| 3 | MerckMRK | $21,1B |
| 4 | Novo Nordisk A SNVO | $19,3B |
| 5 | UnitedHealth GroupUNH | $19,0B |
| 6 | AbbVieABBV | $15,1B |
| 7 | AstraZenecaAZN | $13,7B |
| 8 | GSKGSK | $10,5B |
| 9 | Gilead SciencesGILD | $10,0B |
| 10 | HCA HealthcareHCA | $9,8B |